{"id":"https://openalex.org/W2943917362","doi":null,"title":"Commentary (Glaspy)\u2014Thrombopoietin: Biology and Potential Clinical Applications","display_name":"Commentary (Glaspy)\u2014Thrombopoietin: Biology and Potential Clinical Applications","publication_year":1998,"publication_date":"1998-11-01","ids":{"openalex":"https://openalex.org/W2943917362","mag":"2943917362"},"language":"en","primary_location":{"id":"mag:2943917362","doi":null,"is_oa":false,"landing_page_url":"https://www.cancernetwork.com/cancer-complications/commentary-glaspythrombopoietin-biology-and-potential-clinical-applications","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080006341","display_name":"John A. Glaspy","orcid":"https://orcid.org/0000-0002-1800-9076","observed_orcids":["https://orcid.org/0000-0002-1800-9076"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"John A. Glaspy","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1800-9076","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5080006341"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.36830266,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thrombopoietin","display_name":"thrombopoietin","score":1.0},{"id":"https://openalex.org/keywords/megakaryopoiesis","display_name":"megakaryopoiesis","score":0.8320000171661377},{"id":"https://openalex.org/keywords/myeloid-growth-factors","display_name":"myeloid growth factors","score":0.8009999990463257},{"id":"https://openalex.org/keywords/erythropoietin","display_name":"erythropoietin","score":0.878000020980835},{"id":"https://openalex.org/keywords/cancer-patients","display_name":"cancer patients","score":0.7889999747276306},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.6890000104904175}],"concepts":[{"id":"https://openalex.org/C2777863708","wikidata":"https://www.wikidata.org/wiki/Q424519","display_name":"Thrombopoietin","level":4,"score":0.943203330039978},{"id":"https://openalex.org/C2776958478","wikidata":"https://www.wikidata.org/wiki/Q14914622","display_name":"Thrombopoiesis","level":5,"score":0.8082321882247925},{"id":"https://openalex.org/C2779705218","wikidata":"https://www.wikidata.org/wiki/Q821701","display_name":"Megakaryocyte","level":4,"score":0.6311776638031006},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5271536707878113},{"id":"https://openalex.org/C2778534260","wikidata":"https://www.wikidata.org/wiki/Q218706","display_name":"Erythropoietin","level":2,"score":0.4666203260421753},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43717458844184875},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4219495356082916},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37404441833496094},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2938046455383301},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.22626882791519165},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.15558987855911255},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.10712379217147827}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2943917362","doi":null,"is_oa":false,"landing_page_url":"https://www.cancernetwork.com/cancer-complications/commentary-glaspythrombopoietin-biology-and-potential-clinical-applications","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2412700072","https://openalex.org/W2099883895","https://openalex.org/W2416649595","https://openalex.org/W2073189639","https://openalex.org/W2149120335","https://openalex.org/W628443920","https://openalex.org/W4247588064","https://openalex.org/W2418479804","https://openalex.org/W2009932746","https://openalex.org/W2072565633"],"abstract_inverted_index":{"Given":[0],"the":[1,13,23,38,57,63,68,83,93,101,109,130,134],"clinical":[2,28,87,94],"utility":[3],"of":[4,15,30,41,60,71,82,92],"myeloid":[5],"growth":[6,117],"factors":[7],"and":[8,25,48,62,75,108,118,129],"erythropoietin":[9],"(Epogen,":[10],"Procrit)":[11],"in":[12,44,73],"management":[14],"many":[16],"cancer":[17],"patients,":[18],"it":[19,66],"is":[20,67],"understandable":[21],"that":[22,55,65],"cloning":[24],"introduction":[26],"into":[27],"trials":[29],"thrombopoietin":[31,61,106],"was":[32],"greeted":[33],"with":[34,99],"great":[35],"expectations":[36,128],"for":[37],"future":[39],"utilization":[40],"this":[42],"molecule":[43,112],"oncology.":[45],"Drs.":[46],"Prow":[47],"Vadhan-Raj":[49],"have":[50],"written":[51],"a":[52],"well-referenced":[53],"review":[54],"summarizes":[56],"preclinical":[58],"biology":[59],"evidence":[64],"physiologic":[69],"regulator":[70],"thrombopoiesis":[72],"animals":[74],"humans.":[76],"The":[77],"authors":[78],"also":[79],"synopsize":[80],"some":[81],"data":[84,95],"from":[85,124],"early":[86],"trials.":[88],"My":[89],"own":[90],"interpretation":[91],"obtained":[96],"to":[97],"date":[98],"both":[100,125],"full-length":[102],"clone":[103],"(recombinant":[104],"human":[105,115],"[rhTPO])":[107],"pegylated,":[110],"truncated":[111],"(pegylated":[113],"recombinant":[114],"megakaryocyte":[116],"development":[119],"factor":[120],"[PEG-rHuMGDF])":[121],"differs":[122],"somewhat":[123],"our":[126],"initial":[127],"perspective":[131],"provided":[132],"by":[133],"authors.":[135]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-05-16T00:00:00"}